Non-statin cholesterol-lowering medications may reduce liver cancer risk by 31%, according to new research.
New research suggests non-statin cholesterol-lowering medications, particularly cholesterol absorption inhibitors, may reduce liver cancer risk by 31%. The study, published in the journal CANCER, analyzed UK data and also confirmed that statins are linked to a 35% lower liver cancer risk. The findings require further research, but if confirmed, may inform liver cancer prevention strategies.
July 29, 2024
4 Articles